A. Drljevic-Nielsen

Resistance Training Increases Muscle Strength and Muscle Size in Patients With Liver Cirrhosis.

H. Vilstrup, G. Dam, N. Aagaard, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Early reduction in spectral dual-layer detector CT parameters as favorable imaging biomarkers in patients with metastatic renal cell carcinoma

M. B. Andersen, F. Donskov, F. Rasmussen, 2022, European Radiology.

Early reduction in spectral dual-layer detector CT parameters as favorable imaging biomarkers in patients with metastatic renal cell carcinoma

M. B. Andersen, F. Donskov, F. Rasmussen, 2022, European Radiology.

Prognostic Utility of Parameters Derived From Pretreatment Dual-Layer Spectral-Detector CT in Patients With Metastatic Renal Cell Carcinoma.

M. B. Andersen, J. Thygesen, F. Donskov, 2021, AJR. American journal of roentgenology.

Blood Volume as a new functional image-based biomarker of progression in metastatic renal cell carcinoma

F. Donskov, F. Rasmussen, A. Drljevic-Nielsen, 2021, Scientific Reports.

Baseline blood volume identified by dynamic contrast-enhanced computed tomography as a new independent prognostic factor in metastatic renal cell carcinoma☆

F. Donskov, F. Rasmussen, A. Drljevic-Nielsen, 2020, Translational oncology.

Prognostic value of DCE-CT-derived blood volume and flow compared to core biopsy microvessel density in patients with metastatic renal cell carcinoma

F. Donskov, F. Rasmussen, P. S. Nielsen, 2021, European Radiology Experimental.

Assessment of Correlation between Dual-Energy Ct (De-Ct)-Derived Iodine Concentration and Local Flourodeoxyglucose (Fdg) Uptake in Patients with Primary Non-Small-Cell Lung Cancer

M. B. Andersen, J. Thygesen, J. Nijkamp, 2022, Tomography.

Early reduction in spectral dual-layer detector CT parameters as favorable imaging biomarkers in patients with metastatic renal cell carcinoma

M. B. Andersen, F. Donskov, F. Rasmussen, 2022, European Radiology.

Resistance training improves muscle size and muscle strength in liver cirrhosis – a randomized controlled trial

H. Vilstrup, G. Dam, N. Aagaard, 2018 .

Late adverse events to iodinated contrast media in patients treated with IL-2: a safety report from the Danish Renal Carcinoma Group (DaRenCa) study – 1

E. M. Pedersen, F. Donskov, F. Rasmussen, 2023, Acta radiologica.

Reduced 3‐year risk of hospital admission and mortality after 12‐week resistance training of cirrhosis patients: A follow‐up of a randomized clinical trial

H. Vilstrup, G. Dam, N. Aagaard, 2023, Journal of gastroenterology and hepatology.